Coexpression of CD5 and CD43 predicts worse prognosis in diffuse large B‐cell lymphoma
Abstract Both CD5 and CD43 are expressed on the surface of B lymphocytes of definite phase and associated with the adverse outcome in diffuse large B‐cell lymphoma (DLBCL). However, the relationship between CD5 and CD43 expression and the prognostic value of CD5/CD43 coexpression in DLBCL are unknow...
Main Authors: | Xiao‐bo Ma, Yan‐ping Zhong, Yan Zheng, Jing Jiang, Yin‐ping Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-09-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.1674 |
Similar Items
-
CD5 and CD43 expression are associate with poor prognosis in DLBCL patients
by: Huang Hui, et al.
Published: (2018-11-01) -
CD3+/CD16+CD56+ cell numbers in peripheral blood are correlated with higher tumor burden in patients with diffuse large B-cell lymphoma
by: Anna Twardosz, et al.
Published: (2011-04-01) -
A rare case of de novo CD5+ diffuse large B-cell lymphoma in leukemic phase and positive for CD13
by: Giovanni Carulli, et al.
Published: (2018-01-01) -
A rare case of dual expression of CD5 and CD10 in primary central nervous system diffuse large B‐cell lymphoma with prominent starry sky appearance
by: Colin McCorkle, et al.
Published: (2020-12-01) -
Change of CD20 Expression in Diffuse Large B-Cell Lymphoma Treated with Rituximab, an Anti-CD20 Monoclonal Antibody: A Study of the Osaka Lymphoma Study Group
by: Naoki Wada, et al.
Published: (2009-10-01)